Why the study?
Does antihypertensive treatment to a target of 150/80 mm Hg or reduction of >25/10 mm Hg improve cardiovascular outcomes in patients over 65 years of age?
Does antihypertensive treatment to a target of 150/80 mm Hg or reduction of >25/10 mm Hg improve cardiovascular outcomes in patients over 65 years of age?
This letter highlights the potential under-representation of frail or medically compromised older patients in trials assessing antihypertensive targets.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bahat et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: